A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2027-05-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, multicenter phase II study to evaluate the efficacy and safety of AHB-137 injection in combination with other hepatitis B drugs in participants with HBeAg-negative CHB treated with NAs.